封面
市場調查報告書
商品編碼
2075344

呼吸道融合細胞病毒診斷市場:依檢測類型、最終用戶、應用程式和地區分類

Respiratory Syncytial Virus Diagnostics Market, By Test Type, By End User, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,呼吸道融合細胞病毒(RSV) 診斷市場規模將達到 16.7 億美元,到 2033 年將達到 35.6 億美元。預計從 2026 年到 2033 年,該市場將以 11.4% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 16.7億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 11.40% 2033年市場規模預測: 35.6億美元

全球呼吸道融合細胞病毒(RSV) 診斷市場涵蓋分子診斷、抗原檢測、血清學檢測及類似檢測類型。這些檢測方法應用於兒童、老年科和新生兒篩檢領域,並被醫院、診所和診斷實驗室廣泛採用。隨著各機構日益重視檢測的效能、效率和成本效益,這些領域的應用也穩定成長。

市場動態:

醫院、診所和診斷實驗室需求的成長,對提高效率和可靠性的需求,以及持續的產品創新,預計將是推動全球呼吸道融合細胞病毒(RSV) 診斷市場成長的主要因素。兒童和老年醫療保健領域應用的不斷擴大,進一步加速了這一成長勢頭。

例如,市場新進業者正在部署專為兒童醫療保健應用場景設計的先進解決方案。此外,預計在預測期內,持續的技術進步和策略投資將為市場新進入者創造新的成長機會。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數,介紹了全球呼吸道融合細胞病毒(RSV) 診斷市場主要參與者的概況。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球呼吸道融合細胞病毒(RSV) 診斷市場》報告針對該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球呼吸道融合細胞病毒診斷市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場概覽

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 併購和合作
  • 監管趨勢
  • 主要進展
  • PEST分析
  • 夥伴關係方案
  • 品牌和定價分析
  • 銷售代理情況
  • 波特的分析
  • 技術進步
  • 主要進展
  • 市場趨勢
  • 前景
  • 按銷售收入排名的主要公司

第4章呼吸道融合細胞病毒診斷市場:依檢測類型分類,2026-2033年

  • 分子診斷
  • 抗原檢測
  • 血清學檢測
  • 自動化平台
  • 其他

第5章呼吸道融合細胞病毒診斷市場:依最終使用者分類,2026-2033年

  • 醫院和診所
  • 診斷檢查室
  • 研究機構
  • 即時檢測中心
  • 其他

第6章呼吸道融合細胞病毒診斷市場:依應用領域分類,2026-2033年

  • 兒童醫學
  • 老年護理
  • 新生兒篩檢
  • 社區健康計劃
  • 其他

第7章呼吸道融合細胞病毒診斷市場:依地區分類,2026-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 比荷盧經濟聯盟
    • 丹麥
    • 挪威
    • 瑞典
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 台灣
    • 印度
    • 日本
    • 印尼
    • 馬來西亞
    • 菲律賓
    • 新加坡
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東和非洲
  • 巴林
  • 科威特
  • 阿曼
  • 卡達
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 北非
  • 中非
  • 其他中東國家

第1章 競爭情勢

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • BioMerieux
  • Quidel Corporation
  • Hologic Inc.
  • Siemens Healthineers
  • Fujirebio
  • LumiraDx
  • Meridian Bioscience
  • QIAGEN

第2章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI2038

Respiratory Syncytial Virus Diagnostics Market is estimated to be valued at USD 1.67 billion in 2026 and is expected to reach USD 3.56 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.67 billion
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.40% 2033 Value Projection: USD 3.56 billion

The global respiratory syncytial virus diagnostics market includes offerings that span Molecular Diagnostics, Antigen-Based Tests, and Serological Tests, and similar test type categories. These are applied across Pediatric Care, Geriatric Care, and Neonatal Screening and adopted by Hospitals and Clinics, and Diagnostic Laboratories. As organizations increasingly prioritize performance, efficiency, and cost-effectiveness, adoption across these segments continues to grow steadily.

Market Dynamics:

Increasing demand from Hospitals and Clinics, and Diagnostic Laboratories, the need for improved efficiency and reliability, and ongoing product innovation are major factors expected to drive growth of the global respiratory syncytial virus diagnostics market. Broader adoption across Pediatric Care, and Geriatric Care is reinforcing this momentum.

For instance, market players are introducing advanced solutions designed for Pediatric Care use cases. Moreover, continued technological advancement and strategic investment are expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global respiratory syncytial virus diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, BioMrieux, Quidel Corporation, Hologic Inc., Siemens Healthineers, Fujirebio, LumiraDx, Meridian Bioscience, and QIAGEN, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global respiratory syncytial virus diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory syncytial virus diagnostics market.

Detailed Segmentation:

  • Global Respiratory Syncytial Virus Diagnostics Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
  • Molecular Diagnostics
  • Antigen-Based Tests
  • Serological Tests
  • Automated Platforms
  • Others
  • Global Respiratory Syncytial Virus Diagnostics Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Point-of-Care Testing Centers
  • Research Institutes
  • Others
  • Global Respiratory Syncytial Virus Diagnostics Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Pediatric Care
  • Geriatric Care
  • Neonatal Screening
  • Community Health Programs
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Abbott Laboratories*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • BioMrieux
  • Quidel Corporation
  • Hologic Inc.
  • Siemens Healthineers
  • Fujirebio
  • LumiraDx
  • Meridian Bioscience
  • QIAGEN

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Preview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Test Type
    • Market Snapshot, By End User
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Partnership Scenario
  • Brand and Pricing Analysis
  • Distributors Landscape
  • Porters Analysis
  • Technological Advancements
  • Key Developments
  • Market Trend
  • Future Prospective
  • Top Market Players by Revenue

4. Respiratory Syncytial Virus Diagnostics Market By Test Type, 2026-2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Antigen-Based Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Serological Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Automated Platforms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

5. Respiratory Syncytial Virus Diagnostics Market By End User, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Point-of-Care Testing Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

6. Respiratory Syncytial Virus Diagnostics Market By Application, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Pediatric Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Geriatric Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Neonatal Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Community Health Programs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

7. Respiratory Syncytial Virus Diagnostics Market By Region, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, en2026-2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Benelux
      • Denmark
      • Norway
      • Sweden
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • China
      • Taiwan
      • India
      • Japan
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  • Bahrain
  • Kuwait
  • Oman
  • Qatar
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • North Africa
  • Central Africa
  • Rest of the Middle East

1. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BioMerieux
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Quidel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hologic Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fujirebio
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LumiraDx
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Meridian Bioscience
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

2. Section

  • Research Methodology
  • About Us